Published in JAMA Network Open, the research revisits evidence from nine randomized controlled trials involving 1,258 adults with recurrent depression. The participants were generally in partial or full remission when they entered the original studies, meaning they were not experiencing the most severe phase of an acute depressive episode. The researchers used individual participant data rather than relying only on summary results reported in earlier publications. This approach allowed them to examine changes in symptoms for each participant and compare the likelihood of worsening between people assigned to MBCT and those receiving control treatments.

MBCT combines techniques from cognitive behavioral therapy with structured mindfulness practices. Cognitive behavioral therapy helps patients identify patterns of thinking that can intensify emotional distress and teaches strategies for responding to those patterns differently. Mindfulness training, meanwhile, encourages people to observe thoughts, feelings and bodily sensations without immediately judging or reacting to them. In clinical programs, participants typically practice meditation and mindful movement while learning how to recognize early warning signs of relapse. The aim is not to eliminate difficult thoughts, but to reduce the automatic cycles of rumination and avoidance that can contribute to depression.

The treatment became a major focus of depression research after a landmark 2016 meta-analysis combined results from nine studies and supported MBCT as an effective strategy for preventing relapse. A meta-analysis statistically integrates findings from multiple investigations, increasing the amount of evidence available and making it possible to estimate an overall treatment effect. Those earlier findings helped establish MBCT as a recommended option for people with recurrent depression. But the treatment’s growing popularity also prompted a difficult safety question: could intensive attention to distressing thoughts and emotions make some patients feel worse?

That concern was fueled by limited studies in which patients reported harmful or troubling experiences during mindfulness-based interventions. Such reports deserve attention, particularly when an intervention is delivered across healthcare systems and to large populations. However, the earlier studies generally lacked a control group. Without a comparison group, researchers cannot determine whether symptom worsening was caused by the treatment, by the natural course of depression, by unrelated life events or by the difficulties faced by people receiving other forms of care. Depression symptoms can fluctuate even when no intervention is introduced, making controlled comparisons essential for assessing risk.

The new analysis was designed to address that limitation. The researchers reevaluated the original trial data and defined symptom worsening by examining whether participants showed increased depressive symptoms after treatment relative to their starting point and assigned control condition. They then calculated the odds of worsening in the MBCT groups compared with participants who received alternative interventions or control care. Some control groups included people taking antidepressant medication, allowing the investigators to make additional comparisons with a commonly used medical treatment. Because the analysis used data from randomized trials, assignment to MBCT or control conditions was not determined by patients’ preferences or clinicians’ expectations alone, reducing several sources of bias.

The central result was clear: the data provided no evidence that MBCT increased the odds of depressive symptom worsening compared with control conditions. In some secondary analyses, participants assigned to MBCT appeared to have a lower risk of worsening than those receiving other treatments, including antidepressants. These additional findings should be interpreted cautiously because secondary analyses can be affected by differences among the original trials, treatment formats and comparison groups. Nevertheless, the overall pattern did not support the idea that MBCT carries a general risk of worsening depression for the average patient participating in relapse-prevention treatment.

The findings do not mean that every person will benefit from mindfulness practice or that unwanted experiences are impossible. Psychological treatments can affect patients differently, and some people may find meditation uncomfortable, emotionally demanding or difficult to practice without expert guidance. The trials included in this analysis also focused mainly on adults who had recurrent depression but were in partial or full remission. Their results may therefore not apply directly to people experiencing acute, severe depression, individuals with other psychiatric conditions or patients whose symptoms are changing rapidly. Clinicians still need to monitor patients carefully, discuss possible reactions to treatment and provide alternative care when necessary.

Researchers say the next generation of randomized trials should collect a broader range of information about patient experiences, including both benefits and harms. Standard measures of depressive symptoms are important, but they may not capture feelings such as emotional disconnection, heightened anxiety, distress during meditation or changes in day-to-day functioning. More detailed safety monitoring could help identify whether particular patients, practices or delivery settings are associated with different outcomes. It could also distinguish temporary discomfort that resolves with support from clinically meaningful deterioration requiring a change in treatment.

For now, the study strengthens the evidence supporting MBCT as a relapse-prevention option for recurrent depression. Its importance lies not in showing that mindfulness is universally effective, but in testing a specific safety concern with controlled data from more than a thousand participants. As MBCT continues to spread through hospitals, mental health services and community programs, the analysis offers a measured message: available trial evidence does not show that the therapy makes depressive symptoms worse relative to control care, while future research should continue to examine who benefits most, who may struggle and how psychological treatments can be delivered as safely as possible.

Subject of Research: People

Article Title: Symptom Worsening in Mindfulness-Based Cognitive Therapy

News Publication Date: 20-Aug-2026

Web References: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.29946 ; https://doi.org/10.1001/jamanetworkopen.2026.29946

References: JAMA Network Open; 2016 meta-analysis indexed at https://pubmed.ncbi.nlm.nih.gov/27119968/; World Health Organization depression fact sheet at https://www.who.int/news-room/fact-sheets/detail/depression

Keywords: Mindfulness-based cognitive therapy, depression, relapse prevention, mental health, meta-analysis, symptom worsening, psychotherapy

The study outlined by these researchers marks a pivotal step in addressing the neuropsychological sequelae that many post-COVID-19 patients endure. Cognitive behavioral therapy (CBT), a well-established psychotherapeutic approach, is positioned at the forefront of the intervention. CBT’s role in this context is to recalibrate maladaptive thought patterns and emotional responses linked with the chronic symptoms of long COVID, aiming to enhance patients’ coping mechanisms and ultimately improve quality of life. The protocol’s open-label randomized controlled design ensures rigorous evaluation while allowing participants and clinicians insight into the treatment processes, fostering engagement and adherence.

Exercise training represents the second pillar of this ambitious therapeutic protocol. Accumulating evidence has suggested that physical activity can mitigate symptoms such as fatigue and muscle weakness, frequent in post-COVID-19 condition, by promoting physiological and neurological recovery. The prescribed exercise regimens are carefully tailored to address patients’ varying capacities, ensuring safety while striving to restore endurance and physical function. This approach leverages the well-documented benefits of aerobic and resistance training in modulating systemic inflammation and enhancing neuroplasticity, both critical factors in recovery from viral-induced multisystem disruption.

Perhaps the most intriguing aspect of the trial is the inclusion of cognitive remediation therapy. This specialized intervention targets the cognitive deficits—commonly described as “brain fog”—that many long COVID patients report. Cognitive remediation involves structured activities designed to improve memory, attention, processing speed, and executive functions. By systematically exercising neural pathways affected in post-COVID cognitive impairment, this approach aims to induce neuroplastic changes conducive to functional recovery. Integrating cognitive remediation alongside CBT and physical exercise represents a comprehensive, biopsychosocial approach rarely applied concurrently in this patient population.

The rationale behind combining these diverse modalities reflects emerging recognition that post-COVID-19 condition is not solely a physical disorder but a multifactorial syndrome requiring holistic treatment strategies. Persistent symptoms appear to stem from a combination of ongoing inflammatory processes, autonomic nervous system dysregulation, and direct neuronal injury caused by the SARS-CoV-2 virus or immune-mediated mechanisms. This complexity necessitates therapeutic flexibility that addresses psychological distress, physical deconditioning, and cognitive dysfunction in tandem, rather than in isolation.

Methodologically, the study employs an open-label, randomized controlled design—a gold standard in clinical research that balances scientific rigor with practical feasibility. Though participants and therapists are not blinded to treatment allocation, outcomes will be assessed by independent evaluators, minimizing bias. Additionally, the protocol encompasses detailed baseline and follow-up evaluations spanning neuropsychological tests, physical capacity assessments, and psychometric measures. This comprehensive battery enables investigators to capture nuanced changes across physical and cognitive domains, providing granular insight into treatment efficacy and mechanistic underpinnings.

Recruitment criteria for the study emphasize inclusivity of patients exhibiting a broad spectrum of post-COVID symptoms, particularly focusing on those with cognitive complaints persisting beyond 12 weeks after acute infection. By targeting this chronic phase, the research addresses a critical window where interventions may shift the trajectory from prolonged disability toward meaningful recovery. The protocol also advocates for patient-centered care, incorporating individualized goals and adapting the intensity of interventions to match fluctuating symptom severity.

The implications of this study extend far beyond immediate therapeutic outcomes. By systematically examining the interplay between psychological treatments, physical exercise, and cognitive rehabilitation, the results will likely inform future guidelines for managing complex post-viral syndromes. Furthermore, elucidating which components or combinations yield the greatest benefits could streamline interventions, optimizing resource allocation amid burgeoning long COVID case numbers globally. This approach is particularly relevant given the unprecedented scale and heterogeneous presentations encountered after the pandemic.

In addition to clinical benefits, the study is poised to deepen scientific understanding of post-COVID pathophysiology. Tracking cognitive and physical markers longitudinally in response to intervention will shed light on recovery patterns and potential biomarkers. This knowledge may catalyze development of precision medicine frameworks tailored to individual profiles, potentially involving adjunctive pharmacotherapies that target underlying inflammation or neurodegeneration identified through integrated analyses.

Moreover, the trial’s innovative structure reflects a growing trend toward interdisciplinary collaboration. Bridging psychological science, exercise physiology, neurology, and rehabilitation medicine, the research embodies a holistic paradigm well-suited for tackling multifaceted disorders. This model may serve as a blueprint for managing other chronic illnesses with overlapping cognitive, physical, and emotional dimensions, underscoring the importance of comprehensive care pathways and patient empowerment.

Given the vast public health burden posed by long COVID, findings from this study may resonate deeply with patients, caregivers, and healthcare systems worldwide. Empowering patients with evidence-based interventions to regain function and autonomy can fundamentally alter the post-pandemic landscape, helping mitigate long-term social and economic impacts. The study’s transparent protocol publication fosters interdisciplinary dialogue and accelerates knowledge dissemination, encouraging replication and adaptation across diverse healthcare settings.

The strategic inclusion of cognitive behavioral therapy is particularly promising because it addresses psychological sequelae such as anxiety, depression, and post-traumatic stress that frequently exacerbate cognitive and physical symptoms. By equipping patients with skills to modulate distress and maladaptive behaviors, CBT may enhance adherence to exercise and cognitive rehabilitation components, creating a positive feedback loop that amplifies overall therapeutic benefits.

Exercise training, while widely regarded as beneficial for many chronic conditions, presents unique challenges in long COVID due to symptom variability and potential post-exertional malaise. The trial’s protocol accounts for these concerns through individualized progression and close monitoring, aiming to strike a delicate balance between activity and recovery. Positive outcomes could shift prevailing caution toward more proactive physical rehabilitation strategies.

Cognitive remediation, though well established in psychiatric and neurological populations such as schizophrenia and traumatic brain injury, represents novel territory in post-viral syndromes. Demonstrating its feasibility and efficacy here could pave the way for broader application in infectious disease recovery and neurorehabilitation, expanding therapeutic horizons for patients experiencing cognitive dysfunction secondary to systemic illness.

As the COVID-19 pandemic continues evolving, so too must approaches to managing its lasting effects. This open-label randomized controlled trial epitomizes a forward-thinking, integrative attempt to decode and treat post-COVID-19 condition through an interplay of psychological, physiological, and neurological interventions. By embracing complexity rather than reductionism, it holds promise for transforming long COVID care from reactive symptom management to proactive restoration of health and function.

In summation, the study protocol presented by Gouraud and colleagues heralds a pivotal moment in long COVID research and treatment. Combining cognitive behavioral therapy, carefully calibrated exercise training, and innovative cognitive remediation within a rigorous randomized controlled design offers an unprecedented, multidimensional pathway toward recovery. Its outcomes may not only alleviate suffering for millions but also redefine standards of care in a post-pandemic world increasingly shaped by chronic sequelae of infectious diseases.

Subject of Research: Therapeutic interventions—cognitive behavioral therapy, exercise training, and cognitive remediation—for managing post-COVID-19 condition (long COVID).

Article Title: Cognitive behavioral therapy, exercise training, and cognitive remediation for patients with post-COVID-19 condition: protocol of an open-label randomized controlled trial.

Article References:
Gouraud, C., Ancellin-Geay, A., Verot, C. et al. Cognitive behavioral therapy, exercise training, and cognitive remediation for patients with post-COVID-19 condition: protocol of an open-label randomized controlled trial. BMC Psychol (2025). https://doi.org/10.1186/s40359-025-03820-8

Image Credits: AI Generated

This study, recently published in the reputable journal BMC Psychology on October 6, 2025, elegantly bridges fundamental positive psychology with applied workplace science. By recruiting 100 Japanese full-time employees aged 30 to 49, the researchers established a controlled 12-day online intervention comparing gratitude journaling against a neutral daily event recording task. Participants hailed from diverse sectors, including IT, logistics, and manufacturing, offering a realistic cross-section of modern professional backdrops. This random assignment experimental design enabled the team to isolate the specific psychological influence of directing attention toward gratitude in everyday work life.

Analyses revealed a marked enhancement in overall work engagement among the gratitude journaling cohort, with the most pronounced effect detected in the absorption dimension—the degree to which individuals immerse themselves in tasks cognitively and emotionally. Crucially, these engagement gains were absent in the control group that merely chronicled daily occurrences, underscoring the specificity of gratitude-focused reflection as a psychological driver. Deeper content examination of journal entries indicated that gratitude exercises heightened participants’ recognition of workplace resources, including support from supervisors and cooperative peer dynamics. This finding elegantly corroborates the Job Demands-Resources (JD-R) Model, a dominant theoretical framework positing that awareness and utilization of personal and social resources amplify employee motivation and engagement.

Professor Yamagishi emphasized that this investigation fills a critical empirical gap. “While prior studies often relied on correlational data linking gratitude to well-being indicators, our randomized controlled trial asserts a causal pathway by which intentional gratitude journaling activates work engagement.” This methodological rigor addresses persistent concerns about reverse causation or third-variable confounds in positive psychology research, advancing scientific understanding of gratitude as an intervention rather than a mere correlate.

Beyond primary engagement outcomes, the study uncovered intriguing ancillary effects. Both experimental and control groups exhibited modest but consistent improvements in general gratitude disposition, life satisfaction, and competitive motivation across the 12-day period. This suggests that the disciplined act of daily journaling itself fosters meaningful self-reflective space, potentially inducing gentle psychological benefits unrelated to content focus. Nonetheless, notable divergence emerged in psychological well-being metrics: participants tasked with neutral life event recording experienced slight declines in autonomy and purpose in life, dimensions associated with eudaimonic well-being, while gratitude journalers maintained baseline levels. This nuanced contrast intimates that unstructured reflection may inadvertently amplify awareness of daily stressors or monotony, whereas gratitude prompts facilitate recognition of positive experiences, thereby buffering against such effects.

The theoretical implications of these findings are manifold. By demonstrating that gratitude actively augments awareness of protective workplace resources, the research expands the Job Demands-Resources model’s scope beyond static resource availability to include dynamic cognitive-emotional processes that modify resource salience. Practically, the study advances simple gratitude journaling into an evidence-based, scalable strategy to bolster employee engagement, psychological resilience, and ultimately, organizational climate. Gratitude thus emerges as a modifiable mental skill rather than a transient sentiment, offering a tangible lever for human-centric management practices.

Implementing gratitude journaling requires minimal investment or expertise, rendering it attractive for deployment in diverse occupational contexts globally. Prof. Yamagishi highlights its accessibility, “Given its low-cost and wide applicability, gratitude journaling is poised to become a frontline tool for nurturing positive work culture, well-being, and sustained motivation—without the need for complex training or infrastructural change.” This stands in contrast to many workplace interventions that demand costly workshops, specialized coaching, or technological platforms.

From a neuroscientific perspective, gratitude practices are hypothesized to modulate brain circuits associated with reward, social cognition, and stress regulation. By repeatedly redirecting attention to positive interpersonal exchanges and appreciative cognitions, gratitude journaling may strengthen neuroplasticity in areas such as the prefrontal cortex and anterior cingulate cortex, culminating in enhanced emotional regulation and focused task engagement. Future research could integrate neuroimaging to elucidate these underlying mechanisms, fortifying the empirical base for gratitude interventions.

Moreover, this research aligns with a growing interdisciplinary movement emphasizing the integration of psychological well-being into occupational health paradigms. Within this context, gratitude functions as a scalable psychological resource that organizational leaders and HR professionals can harness to mitigate burnout, reduce turnover, and inspire discretionary effort. It exemplifies how non-monetary, intrinsically motivating factors can complement tangible organizational supports to create holistic strategies for worker flourishing.

Overall, the 12-day gratitude journaling trial advances a compelling narrative: cultivating gratitude is not a passive byproduct of reflection but an active, structured endeavor capable of reshaping workplace experience at fundamental levels. It redefines gratitude from ephemeral emotion to a practical psychological skill that, when systematized, cultivates engagement, sustains well-being, and enriches professional life meaningfully. As global workforces navigate challenges of motivation, mental health, and productivity, this research punctuates a hopeful possibility—simple, intentional gratitude can serve as a catalyst for profound transformation within organizational ecosystems.

Subject of Research: People

Article Title: Enhanced work engagement in Japanese employees following a 12-day online gratitude journal intervention

News Publication Date: 6-Oct-2025

References:
DOI: 10.1186/s40359-025-03494-2

Image Credits:
Professor Noriko Yamagishi from Ritsumeikan University, Japan

Keywords: Psychological Science, Mental Health, Social Sciences, Psychological Theory, Behavioral Psychology, Social Psychology, Human Social Behavior, Motivation